BTIG Maintains Buy on DexCom, Raises Price Target to $150
Portfolio Pulse from richadhand@benzinga.com
BTIG analyst Marie Thibault maintains a Buy rating on DexCom (NASDAQ:DXCM) and raises the price target from $134 to $150.
June 26, 2023 | 3:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BTIG analyst Marie Thibault maintains a Buy rating on DexCom and raises the price target from $134 to $150.
The news of BTIG maintaining a Buy rating on DexCom and raising the price target from $134 to $150 is positive for the company. This indicates that the analyst believes the stock has potential for further growth and is likely to attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100